Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Zoetis (ZTS) Reports Q2 Earnings: What Key Metrics Have to Say
05:01pm, Tuesday, 06'th Aug 2024
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Zoetis Raises Guidance on Revenue Growth
01:45pm, Tuesday, 06'th Aug 2024
Zoetis (ZTS) stock surged in intraday trading Tuesday after the company beat second-quarter revenue expectations and raised its full-year guidance.
Animal Health Firm Zoetis Clocks Strong Q2 Earnings, Companion Animal Operations Boost Confidence For 2024
01:00pm, Tuesday, 06'th Aug 2024
On Tuesday, Zoetis Inc ZTS stock is trading higher after the company reported better-than-expected second-quarter financial results and raised its 2024 guidance above estimates.
Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised
11:45am, Tuesday, 06'th Aug 2024
Zoetis (ZTS) reports better-than-expected Q2 results, beating both earnings and revenue estimates, primarily driven by strong sales of companion animal products. Management raises the 2024 outlook.
Why Zoetis Stock Was Moving Higher Tuesday
11:33am, Tuesday, 06'th Aug 2024
Zoetis beat estimates on the top and bottom lines. Both the companion animal and livestock segments delivered solid growth.
Zoetis Lifts Revenue, Profit Outlook
10:15am, Tuesday, 06'th Aug 2024
Adjusted earnings per share topped analyst estimates. Net income fell 7% year over year to $624 million.
Zoetis (ZTS) Tops Q2 Earnings and Revenue Estimates
09:10am, Tuesday, 06'th Aug 2024
Zoetis (ZTS) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.41 per share a year ago.
Zoetis lifts 2024 results forecasts on strong demand for pet treatments
08:04am, Tuesday, 06'th Aug 2024
Animal healthcare company Zoetis raised its annual profit and revenue forecasts on Tuesday, betting on strong demand for its medicines and vaccines for pets.
UTHR or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Friday, 02'nd Aug 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks presents investors with the better value op
My Top 15 High-Growth Dividend Stocks For August 2024
05:43am, Friday, 02'nd Aug 2024
The SPDR S&P 500 ETF Trust posted a 1.21% gain in July, underperforming Vanguard's Dividend Appreciation Index Fund ETF Shares by +3.97%. The top 15 dividend growth stocks for August 2024 offer an ave
Zoetis (ZTS) Advances While Market Declines: Some Information for Investors
07:15pm, Thursday, 01'st Aug 2024
In the most recent trading session, Zoetis (ZTS) closed at $182.42, indicating a +1.32% shift from the previous trading day.
Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program
04:30pm, Thursday, 01'st Aug 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has approved a multi-year $6 billion share repurchase program as part of it
Unveiling Zoetis (ZTS) Q2 Outlook: Wall Street Estimates for Key Metrics
10:20am, Thursday, 01'st Aug 2024
Beyond analysts' top -and-bottom-line estimates for Zoetis (ZTS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?
11:07am, Tuesday, 30'th Jul 2024
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis Inc Is Being Investigated By The Schall Law Firm And Investors With Losses Are Encouraged To Make Contact
09:30am, Tuesday, 30'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoe
